Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-10-21

Clinical Trial Update: EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting [NA]

View source ↗

Summary

The EPIC US feasibility trial completed, evaluating the FiberNet Emboli Protection Device during carotid artery stenting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FiberNet Emboli Protection Device

Snippet

Sponsor: Lumen Biomedical | Conditions: Carotid Artery Stenosis | NA | Status: COMPLETED